Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.

N L Bartlett; G R Petroni; B A Parker; N D Wagner; J P Gockerman; G A Omura; G P Canellos; M Robert; J L Johnson; B A Peterson

doi:10.1002/1097-0142(20010715)92:2<207::aid-cncr1311>3.0.co;2-d

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.

Identifier:nobleid.org/w1/20260515/82BC1AF8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/82BC1AF8.svg?ark=w1%2F20260515%2F82BC1AF8)](https://nobleid.org/work/w1/20260515/82BC1AF8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854.

Identifier:nobleid.org/w1/20260515/82BC1AF8

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/82BC1AF8.svg?ark=w1%2F20260515%2F82BC1AF8)](https://nobleid.org/work/w1/20260515/82BC1AF8)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work